{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:32:49Z","timestamp":1791192769063,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.psyneuen.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T03:28:27Z","timestamp":1363404507000},"page":"1824-1828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["NGF serum levels variations in major depressed patients receiving duloxetine"],"prefix":"10.1016","volume":"38","author":[{"given":"Matteo","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Escelsior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Contini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Colicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"de Berardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantaleo","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2013.02.009_bib0005","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.psyneuen.2009.05.003","article-title":"Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: involvement of the HPA axis","volume":"34","author":"Aisa","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0091-3057(95)02111-6","article-title":"NGF regulatory role in stress and coping of rodents and humans","volume":"54","author":"Alleva","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(02)00757-8","article-title":"Stress and nerve growth factor: findings in animal models and humans","volume":"73","author":"Aloe","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.yfrne.2009.05.002","article-title":"The NGF saga: from animal models of psychosocial stress to stress-related psychopathology","volume":"30","author":"Cirulli","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1471-4159.2010.06622.x","article-title":"Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity","volume":"113","author":"Counts","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11011-006-9013-6","article-title":"Early maternal separation followed by later stressors leads to dysregulation of the HPA-axis and increases in hippocampal NGF and NT-3 levels in a rat model","volume":"21","author":"Faure","year":"2006","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(01)00278-8","article-title":"Changes in plasma nerve growth factor levels in older adults associated with chronic stress","volume":"116","author":"Hadjiconstantinou","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-010-2120-4","article-title":"The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs","volume":"215","author":"Hassanzadeh","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0006-8993(01)02611-7","article-title":"Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat","volume":"907","author":"Hellweg","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-1004594","article-title":"Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment","volume":"41","author":"Hellweg","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","article-title":"Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment","volume":"49","author":"Pariante","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-3223(00)01047-7","article-title":"Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease","volume":"49","author":"Rattray","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.expneurol.2006.11.009","article-title":"Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression","volume":"204","author":"Schulte-Herbruggen","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0070","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/jnr.22080","article-title":"Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress","volume":"87","author":"Schulte-Herbruggen","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psyneuen.2013.02.009_bib0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.psychres.2010.12.017","article-title":"The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia","volume":"189","author":"Xiong","year":"2011","journal-title":"Psychiatry Res."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:45:05Z","timestamp":1759682705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453013000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0306453013000474"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.02.009","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NGF serum levels variations in major depressed patients receiving duloxetine","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}